Rats displaying distinct exploratory activity also have different expression patterns of γ-aminobutyric acid- and cholecystokinin-related genes in brain regions

Bert, 2001, Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety, Pharmacol. Biochem. Behav., 70, 411, 10.1016/S0091-3057(01)00629-3 Bradwejn, 1984, Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones, Nature, 312, 363, 10.1038/312363a0 Bueno, 2005, Panicolytic-like effect induced by the stimulation of GABA(A) and GABA(B) receptors in the dorsal periaqueductal grey of rats, Eur. J. Pharmacol., 516, 239, 10.1016/j.ejphar.2005.04.045 Chacur, 1999, Immediate increase in benzodiazepine binding in rat brain after a single brief experience in the plus maze: a paradoxical effect, Neurosci. Lett., 269, 29, 10.1016/S0304-3940(99)00425-5 Chen, 2006, Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse, Proc. Natl. Acad. Sci., 103, 3881, 10.1073/pnas.0505407103 Clark, 1986, A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK 8 and CCK 4 cholecystokinin receptor binding site, J. Neurochem., 46, 1094, 10.1111/j.1471-4159.1986.tb00623.x Cope, 2002, Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurons target different domains of pyramidal cells in the CA1 area of the rat hippocampus, Neuroscience, 109, 63, 10.1016/S0306-4522(01)00440-7 Da Cunha, 1992, Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist, Funct. Neurology, 7, 401 Espejo, 1997, Structure of the mouse behaviour on the elevated plus-maze test of anxiety, Behav. Brain Res., 86, 105, 10.1016/S0166-4328(96)02245-0 Fekete, 1984, Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats, Eur. J. Pharmacol., 98, 79, 10.1016/0014-2999(84)90111-0 Ferraro, 1999, Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices, J. Neurochem., 73, 1973 Hama, 1987, Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics, Neurochem. Res., 12, 729, 10.1007/BF00970529 Handley, 1984, Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour, Naunyn-Schmiedeberg's Arch. Pharmacol., 327, 1, 10.1007/BF00504983 Harro, 1990, Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics, Behav. Brain Res., 39, 63, 10.1016/0166-4328(90)90121-T Hendry, 1984, Neuropeptide-containing neurons of the cerebral cortex are also GABAergic, Proc. Natl. Acad. Sci. U. S. A., 81, 6526, 10.1073/pnas.81.20.6526 Kõks, 1997, Relation of exploratory behaviour of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels, Eur. Neuropsychopharmacol., 7, 289, 10.1016/S0924-977X(97)00034-5 Kõks, 2004, A screen for genes induced in the amygdaloid area during cat odor exposure, Genes Brain Behav., 3, 80, 10.1046/j.1601-183x.2003.00047.x Kosaka, 1985, GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus, J. Comp. Neurol., 239, 420, 10.1002/cne.902390408 Kozorovitskiy, 2004, Dominance hierarchy influences adult neurogenesis in the dentate gyrus, J. Neurosci., 24, 6755, 10.1523/JNEUROSCI.0345-04.2004 Landgraf, 2002, High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety, Behav. Genet., 32, 301, 10.1023/A:1020258104318 Liebsch, 1998, Behavioural, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behaviour, Neuropsychopharmacology, 19, 381, 10.1016/S0893-133X(98)00042-6 Lister, 1987, The use of a plus-maze to measure anxiety in the mouse, Psychopharmacology (Berlin), 92, 180, 10.1007/BF00177912 McDonald, 1989, Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala, Neurosci. Lett., 100, 53, 10.1016/0304-3940(89)90659-9 McDonald, 2004, Immunocytochemical localization of GABABR1 receptor subunits in the basolateral amygdala, Brain Res., 1018, 147, 10.1016/j.brainres.2004.05.053 Miller, 1997, Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons, J. Neurosci., 17, 4994, 10.1523/JNEUROSCI.17-13-04994.1997 Mombereau, 2005, Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits, NeuroReport, 16, 307, 10.1097/00001756-200502280-00021 Nelovkov, 2003, Rats with low exploratory activity in the elevated plus-maze have the increased expression of limbic system-associated membrane protein gene in the periaqueductal grey, Neurosci. Lett., 352, 179, 10.1016/j.neulet.2003.08.061 Netto, 2004, Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray, Neuropsychopharmacology, 29, 101, 10.1038/sj.npp.1300334 Noble, 1999, International Union of Pharmacology: XXI. Structure, distribution, and functions of cholecystokinin receptors, Pharmacol. Rev., 51, 745 Panksepp, 1998 Pellow, 1986, Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat, Pharmacol. Biochem. Behav., 24, 525, 10.1016/0091-3057(86)90552-6 Pellow, 1985, Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods, 14, 149, 10.1016/0165-0270(85)90031-7 Perez de la Mora, 1993, Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas, Eur. J. Pharmacol., 250, 423, 10.1016/0014-2999(93)90029-H Pimenta, 1995, The limbic system-associated membrane protein is an Ig superfamily member that mediates selective neuronal growth and axon targeting, Neuron, 15, 287, 10.1016/0896-6273(95)90034-9 Pratt, 1995, The benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain, Neurosci. Lett., 184, 197, 10.1016/0304-3940(94)11205-W Raab, 1986, Behavioural, physiological and immunological consequences of social status and aggression in chronically coexisting resident–intruder dyads of male rats, Physiol. Behav., 36, 223, 10.1016/0031-9384(86)90007-7 Rägo, 1988, Behavioural differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex, Naunyn-Schmiedeberg's Arch. Pharmacol., 337, 675, 10.1007/BF00175795 Rägo, 1991, Correlation between exploratory activity in an elevated plus-maze and number of central and peripheral benzodiazepine binding sites, Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 301, 10.1007/BF00251130 Rasmussen, 1993, The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle, NeuroReport, 5, 154, 10.1097/00001756-199311180-00015 Raud, 2003, Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice, Psychopharmacology (Berlin), 168, 417, 10.1007/s00213-003-1453-7 Raud, 2005, Targeted invalidation of CCK(2) receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test, Psychopharmacology (Berlin)., 181, 347, 10.1007/s00213-005-2255-x Rodgers, 1997, Animal models of ‘anxiety’: where next?, Behav. Pharmacol., 8, 477, 10.1097/00008877-199711000-00003 Russo, 1993, Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety, Psychopharmacology (Berlin), 110, 198, 10.1007/BF02246973 Singh, 1992, The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988, Br. J. Pharmacol., 105, 8, 10.1111/j.1476-5381.1992.tb14201.x Swanson, 1998 Van Dijk, 1984, Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand, J. Neurosci., 4, 1021, 10.1523/JNEUROSCI.04-04-01021.1984 Wang, 2003, cDNA microarray analysis of gene expression in anxious PVG and SD rats after cat-freezing test, Exp. Brain Res., 149, 413, 10.1007/s00221-002-1369-1 Wunderlich, 2002, Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behaviour, Psychopharmacology (Berlin), 164, 193, 10.1007/s00213-002-1181-4 Zanoveli, 2004, Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze, Peptides, 25, 1935, 10.1016/j.peptides.2004.06.016